1. Home
  2. ENTA vs AISP Comparison

ENTA vs AISP Comparison

Compare ENTA & AISP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENTA
  • AISP
  • Stock Information
  • Founded
  • ENTA 1995
  • AISP 2006
  • Country
  • ENTA United States
  • AISP United States
  • Employees
  • ENTA N/A
  • AISP N/A
  • Industry
  • ENTA Biotechnology: Pharmaceutical Preparations
  • AISP Blank Checks
  • Sector
  • ENTA Health Care
  • AISP Finance
  • Exchange
  • ENTA Nasdaq
  • AISP Nasdaq
  • Market Cap
  • ENTA 164.6M
  • AISP 186.4M
  • IPO Year
  • ENTA 2013
  • AISP N/A
  • Fundamental
  • Price
  • ENTA $11.29
  • AISP $6.01
  • Analyst Decision
  • ENTA Strong Buy
  • AISP Strong Buy
  • Analyst Count
  • ENTA 6
  • AISP 1
  • Target Price
  • ENTA $20.83
  • AISP $6.00
  • AVG Volume (30 Days)
  • ENTA 1.5M
  • AISP 1.4M
  • Earning Date
  • ENTA 11-24-2025
  • AISP 11-13-2025
  • Dividend Yield
  • ENTA N/A
  • AISP N/A
  • EPS Growth
  • ENTA N/A
  • AISP N/A
  • EPS
  • ENTA N/A
  • AISP N/A
  • Revenue
  • ENTA $64,806,000.00
  • AISP $13,724,085.00
  • Revenue This Year
  • ENTA $0.07
  • AISP $34.52
  • Revenue Next Year
  • ENTA N/A
  • AISP $59.54
  • P/E Ratio
  • ENTA N/A
  • AISP N/A
  • Revenue Growth
  • ENTA N/A
  • AISP N/A
  • 52 Week Low
  • ENTA $4.09
  • AISP $1.90
  • 52 Week High
  • ENTA $15.34
  • AISP $7.66
  • Technical
  • Relative Strength Index (RSI)
  • ENTA 59.34
  • AISP 56.67
  • Support Level
  • ENTA $9.91
  • AISP $5.02
  • Resistance Level
  • ENTA $11.59
  • AISP $7.20
  • Average True Range (ATR)
  • ENTA 1.52
  • AISP 0.49
  • MACD
  • ENTA 0.19
  • AISP 0.08
  • Stochastic Oscillator
  • ENTA 52.96
  • AISP 47.81

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.

About AISP Airship AI Holdings Inc.

Airship AI Holdings Inc is a robust AI-driven data management platform that solves complex data challenges for large institutions operating in dynamic and mission-critical environments with rapidly increasing volumes of data being ingested from a similarly rapidly growing number of data sources. Its primary offerings include Outpost AI, Acropolis, and Airship Command. Its offerings allow customers to manage their data across the full data lifecycle, when and where need it, using a secure permission-based architecture.

Share on Social Networks: